Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Hekang Pharmaceutical is a specialized pharmaceutical company located in the Hangzhou Economic and Technological Development Zone, China. Established in 2003, the company focuses on the research, development, and large-scale manufacturing of chemical pharmaceuticals, including both finished dosage forms and active pharmaceutical ingredients (APIs). Its core therapeutic areas encompass cardiovascular health, gastroenterology, and anti-infectives, with a portfolio featuring widely used generic medications like amlodipine and omeprazole. The company operates state-of-the-art, GMP-compliant facilities designed for the production of tablets, capsules, and granules. Hekang aims to enhance healthcare accessibility by providing cost-effective and high-quality medicinal products to the domestic market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hangzhou Hekang Pharmaceutical.